Stocks and Investing Stocks and Investing
Fri, May 27, 2022

Oren Livnat Maintained (AVDL) at Strong Buy with Decreased Target to $13 on, May 27th, 2022


Published on 2024-10-27 21:19:36 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Decreased Target from $17 to $13 on, May 27th, 2022.

Oren, nor any peers, have made any analyst calls on AVDL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources